FGF21 and metabolic dysfunction-associated steatotic liver disease: If our assumption turned out to be true, then a decrease of FGF21 level in NAFLD patient might indicate a decompensatory stage of the disease and might accompany with an acute deterioration of a series of metabolic disorders.